Background: Therapeutic plasma exchange (TPE) for desensitization in ABO incompatible kidney transplantation (KT) has raised concerns regarding efficiency and safety. The purpose of this study was to determine the number of TPE prior to KT required to reach target titer for KT according to ABO blood groups. Methods: The distribution of ABO antibody (Ab) titer of 117 patients was investigated. The relationship between initial ABO Ab and number of TPEs required to reach target titer to ≤1:8 prior to KT was evaluated retrospectively according to blood groups and ABO Ab classes. Results: The initial IgG ABO Ab titers were the highest in blood O group recipients, and the average number± standard deviations (range) of TPEs performed prior to ABO incompatible KT was 3.0±1.1 (0∼5) in blood group A, 3.7±1.5 (0∼8) in blood group B, and 5.3±1.9 (2∼13) in blood group O, respectively. The best correlation was observed in the linear relationship between initial ABO Ab titer and number of TPEs required (y=0.6829x+ 0.0523, R 2 =0.946, x=log2 initial ABO Ab titer, y=number of TPE required), regardless of the specific ABO blood group. Conclusion: The number of TPEs can be highly deduced from initial ABO Ab titer and our developed equation in desensitization programs would help increase the efficiency of TPE and patient safety. (Korean J Blood Transfus 2016;27:22-30) 
Introduction
ABO-incompatible kidney transplantation (iABO KT) has expanded the donor pool by increasing the availability of transplantable organs, decreasing the waiting period. The blood type barrier is a major obstacle to the naturally occurring anti-A or anti-B, which cause hyperacute rejection in preliminary cases, by not removing them from the circulation at the time of transplantation. 1) Therapeutic plasma exchange (TPE) before an iABO KT may be used to prevent hyperacute rejection, and posttransplantation TPE is often used to treat antibody-mediated rejection that occurs in this setting. 2) Currently, most courses of desensitization include
TPE followed by intravenous immunoglobulin (IVIG)
as a preconditioning and medication of thymoglobu- The substance removal kinetics of TPE is known to be exponential based on a several compartment models, and post-exchange events with optimal intervals between the procedures have been developed.
12)
The objective of our study was to define the number of TPEs according to initial ABO Ab titers to guide clinicians in the design of ideal strategies for patients preparing iABO KT.
Materials and Methods

Patients
One hundred seventeen end-stage renal disease 
Pre-transplantation conditioning
All patients underwent the pre-transplantation conditioning protocol that consists of TPE followed 
Statistical analysis
The two-sample t-test was used to compare ABO 
Results
Patients
Among the total of 117 patients, 80 patients were male (68.4%) and the median age of the patients was 46 years (interquartile range 37∼53 years).
Transplantation from AB donors to B recipients (AB →B), A→B, and B→A were majority pair combinations including approximately 19.7%, 17.9%, and 17.1% of the population, respectively, and three cases (2.6%) of AB→O were performed (Table 1) .
Initial ABO antibody and TPE
The distribution of initial IgG or IgM ABO Ab titer is illustrated according to recipients' blood types (Fig. 1) .
The initial ABO Ab titers of blood group O recipients were significantly higher in case of IgG, com- (Fig. 2) . 
Outlier patients
Discussion
The findings of our retrospective study confirm that the number of TPEs required to proceed to iABO KT shows an exponential relationship be-tween initial ABO Ab, which was previously reported by Lawrence et al. 15) Although his study focused on IgG Ab titer, we considered all aspects in IgG, IgM, and either higher Ab titer of IgG or IgM classes, because there is currently a debate regarding which immunoglobulin class is more potent in the course of rejection. 16) In addition, we focused on the correlation according to the recipients' blood group and ABO Ab titer, which is critical for graft survival. 17) This is the first study to suggest a number of TPEs based on the investigation considering the recipients' specific blood types and ABO Ab class.
As TPE removes substances present intravascularly, it can be expected that removal efficacy is superior
in IgM compared to that in IgG or IgA, as the extravascular distribution was found to be 55%, 58%, and 22%, respectively. 23)
The strength of this study is that the TPE protocol is universally applied among most cases, as AB type FFP is used in the two last sessions before transplantation after several TPEs with albumin. Therefore, the number of TPEs acquired from our equation can be easily adopted. The clinical importance of immunoglobulin classes is unclear; however, our approach is safe for preserving good allograft outcomes. The Ab titer can be quantified using advanced methodologies, such as flow cytometry or gel techniques, which can provide more accurate correlations. 24, 25) In conclusion, we suggest that a number of TPEs can be highly deduced from initial ABO Ab titers regardless of the specific blood type or ABO Ab classes; therefore, can contribute to the reduction in patients' side effects as well as financial costs. 
